(Q45948420)

English

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.

scientific article published in October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

Tore Wentzel-Larsen

6

object named as

Tore Wentzel-Larsen

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

Bengt Glimelius

7

object named as

Bengt Glimelius

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

author name string

Halfdan Sorbye

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

Per Pfeiffer

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

Nina Cavalli-Björkman

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

Camilla Qvortrup

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

Mari H Holsen

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

115

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

20

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

4679-4687

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Successfully improving access and accrual to oncology clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial accrual among new cancer patients at a community-based cancer center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Why don't cancer patients enter clinical trials? A review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing inclusion of patients with malignancies in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Participation of patients 65 years of age or older in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-enrolment of ovarian cancer patients in clinical trials: reasons and background

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in elderly patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24527

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24527

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19562777

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45948420&oldid=2153138888"